At the 2025 World Internet Conference in Wuzhen, the global spotlight once again turned to this picturesque water town in southern China, as leaders from the internet and technology innovation sectors ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

Artificial intelligence (AI) for science has rapidly gained momentum at an extreme pace. Models trained on the scientific record are generating hypotheses and even running experiments in automated ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

The Accreditation Council for Medical Affairs (ACMA) is raising the bar for excellence in life sciences by incorporating artificial intelligence training into its flagship certification, The Board ...